- Home
- AIEV vs BIAF Comparison
AIEV vs BIAF Comparison
Compare AIEV & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIEV
- BIAF
- Stock Information
- Founded
- AIEV 2011
- BIAF 2014
- Country
- AIEV United States
- BIAF United States
- Employees
- AIEV N/A
- BIAF N/A
- Industry
- AIEV Blank Checks
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AIEV Finance
- BIAF Health Care
- Exchange
- AIEV Nasdaq
- BIAF Nasdaq
- Market Cap
- AIEV 14.0M
- BIAF 14.5M
- IPO Year
- AIEV N/A
- BIAF 2022
- Fundamental
- Price
- AIEV $0.32
- BIAF $0.95
- Analyst Decision
- AIEV
- BIAF Strong Buy
- Analyst Count
- AIEV 0
- BIAF 1
- Target Price
- AIEV N/A
- BIAF $6.00
- AVG Volume (30 Days)
- AIEV 7.0M
- BIAF 148.5K
- Earning Date
- AIEV 02-15-2025
- BIAF 11-14-2024
- Dividend Yield
- AIEV N/A
- BIAF N/A
- EPS Growth
- AIEV N/A
- BIAF N/A
- EPS
- AIEV N/A
- BIAF N/A
- Revenue
- AIEV N/A
- BIAF $9,367,785.00
- Revenue This Year
- AIEV N/A
- BIAF $285.51
- Revenue Next Year
- AIEV N/A
- BIAF $20.05
- P/E Ratio
- AIEV N/A
- BIAF N/A
- Revenue Growth
- AIEV N/A
- BIAF 2813.87
- 52 Week Low
- AIEV $0.22
- BIAF $0.83
- 52 Week High
- AIEV $12.12
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- AIEV N/A
- BIAF 39.56
- Support Level
- AIEV N/A
- BIAF $0.88
- Resistance Level
- AIEV N/A
- BIAF $1.29
- Average True Range (ATR)
- AIEV 0.00
- BIAF 0.14
- MACD
- AIEV 0.00
- BIAF 0.01
- Stochastic Oscillator
- AIEV 0.00
- BIAF 25.93
About AIEV Thunder Power Holdings Inc. Common Stock
Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.